Tag archive for ‘Heptares Therapeutics’
Jewish Business News On Wednesday, November 25th, 2015

Teva Pharmaceuticals licenses migraine treatment candidates

  Teva Pharmaceutical Industries Ltd. and UK-based Heptares Therapeutics, a subsidiary of Tokyo-based Sosei Group have announced a licensing of its migraine treatment candidates. Under the agreement More...

Wordpress site Developed by Fixing WordPress Problems